Stem Cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 27, 2007
app pub date -
Feb 14, 2005
filing date -
Feb 12, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A novel human embryonic stem cell line (hES-NCL1) is described together with a method for culturing a blastocyst and obtaining an embryonic stem cell line therefrom. Also described is the spontaneous partial differentiation of the embryonic stem cell line so obtained to produce fibroblast-like cells which act as an autogeneic feeder system to the stem cells. A novel fibroblast-like cell line hESC-NCL is described.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully